£78.06

Springer Staging Neuropsychiatric Disorders: Implications for Etiopathogenesis and Treatment

Price data last checked 47 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 44 days • 44 data points (No recent data available)

Historical
Generating forecast...
£97.62 £68.23 £74.64 £81.05 £87.47 £93.88 £100.29 25 January 2026 04 February 2026 15 February 2026 26 February 2026 09 March 2026

Price Distribution

Price distribution over 44 days • 6 price levels

Days at Price
Current Price
8 days 18 days 1 day · current 5 days 5 days 7 days 0 5 9 14 18 £71 £77 £78 £82 £83 £98 Days at Price

Price Analysis

Most common price: £77 (18 days, 40.9%)

Price range: £71 - £98

Price levels: 6 different prices over 44 days

Description

Product Description This book features chapters by participants of the International Meeting on Staging Neuropsychiatric Disorders: Implications for Etiopathogenesis and Treatment. It highlights prevention and treatment strategies at different stages of disease progression. From the Back Cover Book chapters are authored by participants in the International Meeting on Staging Neuropsychiatric Disorders: Implications for Etiopathogenesis and Treatment, held in Mojácar (Almería) Spain from 14-18 October 2009. Chapters are organized into four sections on themes encompassed by Staging Neuropsychiatric Disorders: 1) Clinical Staging in the Pathophysiology of Psychotic and Affective Disorders, 2) Staging Perspectives in Neurodevelopmental Aspects of Neuropsychiatry, 3) Epigenetics and Biomarkers in the Staging of Neuropsychiatric Disorders, and 4) Staging Neurodegenerative Disorders. This volume should serve as a resource for physicians and neuroscientists alike, highlighting the importance of staging neuropsychiatric disorders and the underlying mechanistic dysfunction, for prevention and treatment strategies at different stages of disease progression.   Earlier volumes in the series, published by the Fundación Cerebro y Mente in Madrid, Spain: 1.       Depressive, Anxiety and Drug Abuse Disorders Eds: T. Palomo and T. Archer 2.       Schizophrenia, Movement Disorders and Age Related Cognitive Disorders Eds.: T. Palomo, T. Archer and R.J. Beninger 3.       Dopamine Disease States Eds.: R.J. Beninger, T. Palomo and T. Archer 4.       Interactive Monoaminergic Disorders Eds.: T. Palomo, R.J. Beninger and T. Archer 5.       Neurodegenerative Brain Disorders Eds.: T. Palomo, R.J. Beninger and T. Archer 6.       Neurodevelopmental Liabilities in Brain Disease States Eds.: R.J. Beninger, T. Palomo, R.M. Kostrzewa and T. Archer 7.       Gene-Environment Interplay in Brain Disease States Eds.: T. Palomo, R.J. Beninger, R.M. Kostrzewa and T. Archer 8.       Implications of CoMorbidity for Etiology and Treatment of Neuropsychiatric Disorders Eds.: T. Palomo, R.J. Beninger, R.M. Kostrzewa and T. Archer 9.       Beyond Neuropsychiatric Diagnostics: Symptoms not Disorders Eds.: T. Palomo, R.J. Beninger, R.M. Kostrzewa and T. Archer

Product Specifications

Barcode

No barcode data available